Barnes Wealth Management Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
CWP
DADC
Barnes Wealth Management Group's PFE Position: Q2 2026 in Review
Barnes Wealth Management Group increased its Pfizer (PFE) stake by 5.4% in Q2 2026, buying an estimated $20.8K and bringing the position to 15,391 shares worth $371K. The position accounts for 0.17% of the portfolio, ranked #124.
Barnes Wealth Management Group first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $411K in Q3 2025. 1,005 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Barnes Wealth Management Group held 15,391 shares of Pfizer worth $371K as of Q2 2026.
- Barnes Wealth Management Group bought 795 Pfizer shares in Q2 2026, an estimated $20.8K.
- Pfizer made up 0.17% of Barnes Wealth Management Group's portfolio in Q2 2026, its #124 holding.
- Barnes Wealth Management Group first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
- Barnes Wealth Management Group's Pfizer position peaked at $411K in Q3 2025.
- 1,005 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Barnes Wealth Management Group's 13F filing for Q2 2026, filed 24 Jul 2026.